ATE226083T1 - Verkapselung wasserlöslicher peptide - Google Patents

Verkapselung wasserlöslicher peptide

Info

Publication number
ATE226083T1
ATE226083T1 AT99933630T AT99933630T ATE226083T1 AT E226083 T1 ATE226083 T1 AT E226083T1 AT 99933630 T AT99933630 T AT 99933630T AT 99933630 T AT99933630 T AT 99933630T AT E226083 T1 ATE226083 T1 AT E226083T1
Authority
AT
Austria
Prior art keywords
encapsulation
water soluble
soluble peptides
peptides
water
Prior art date
Application number
AT99933630T
Other languages
English (en)
Inventor
Francis X Ignatious
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Priority claimed from PCT/US1999/014869 external-priority patent/WO2000004916A1/en
Application granted granted Critical
Publication of ATE226083T1 publication Critical patent/ATE226083T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1611Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • A61K38/09Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/31Somatostatins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1641Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647Polyesters, e.g. poly(lactide-co-glycolide)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02Making microcapsules or microballoons
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02Making microcapsules or microballoons
    • B01J13/06Making microcapsules or microballoons by phase separation
    • B01J13/12Making microcapsules or microballoons by phase separation removing solvent from the wall-forming material solution

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Dispersion Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
AT99933630T 1998-07-23 1999-07-09 Verkapselung wasserlöslicher peptide ATE226083T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12165398A 1998-07-23 1998-07-23
US9391498P 1998-07-23 1998-07-23
PCT/US1999/014869 WO2000004916A1 (en) 1998-07-23 1999-07-09 Encapsulation of water soluble peptides

Publications (1)

Publication Number Publication Date
ATE226083T1 true ATE226083T1 (de) 2002-11-15

Family

ID=26788040

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99933630T ATE226083T1 (de) 1998-07-23 1999-07-09 Verkapselung wasserlöslicher peptide

Country Status (12)

Country Link
EP (1) EP1098660B1 (de)
JP (1) JP2002521343A (de)
AR (1) AR019466A1 (de)
AT (1) ATE226083T1 (de)
AU (1) AU4964699A (de)
CA (1) CA2338345A1 (de)
DE (1) DE69903553T2 (de)
DK (1) DK1098660T3 (de)
ES (1) ES2185373T3 (de)
NO (1) NO20010358L (de)
PT (1) PT1098660E (de)
RU (1) RU2216343C2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007001865A (ja) * 2003-09-16 2007-01-11 Ltt Bio-Pharma Co Ltd 脂溶性薬物封入微粒子、その製造法およびそれを含有する製剤
MY158342A (en) * 2003-11-14 2016-09-30 Novartis Ag Pharmaceutical composition
JP4872813B2 (ja) * 2007-06-08 2012-02-08 栗田工業株式会社 透過膜の阻止率向上方法および透過膜処理方法
JP4568335B2 (ja) * 2008-02-04 2010-10-27 三洋化成工業株式会社 抗体含有溶液コントロール試薬
DE102009033196A1 (de) * 2009-07-14 2011-01-20 Beiersdorf Ag Kosmetische Zubereitung mit einem Gehalt an dispergierten Mikrosphären
JP5655147B2 (ja) * 2010-08-20 2015-01-14 セルリアン・ファーマ・インコーポレイテッド 治療用ペプチド−ポリマーの複合体、粒子、組成物および関連の方法
EP2797585A4 (de) * 2011-12-29 2015-10-07 Latitude Pharmaceuticals Inc Stabilisierte glucagonnanoemulsionen
CN107106659B (zh) 2014-10-27 2022-07-08 莱迪杜德制药公司 肠胃外胰高血糖素制剂
RU2736590C2 (ru) 2016-02-16 2020-11-18 Стронгбридж Даблин Лимитед Велдореотид, обладающий плохой растворимостью в физиологических условиях, для применения при лечении акромегалии, акромегалии со злокачественным новообразованием, экспрессирующих sst-r5 опухолей, диабета 2 типа, гипергликемии и опухолей, связанных с гормонами

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH683149A5 (fr) * 1991-07-22 1994-01-31 Debio Rech Pharma Sa Procédé pour la préparation de microsphères en matériau polymère biodégradable.

Also Published As

Publication number Publication date
NO20010358D0 (no) 2001-01-22
ES2185373T3 (es) 2003-04-16
DE69903553D1 (de) 2002-11-21
CA2338345A1 (en) 2000-02-03
PT1098660E (pt) 2003-02-28
RU2216343C2 (ru) 2003-11-20
JP2002521343A (ja) 2002-07-16
DK1098660T3 (da) 2003-02-17
NO20010358L (no) 2001-03-22
EP1098660A1 (de) 2001-05-16
DE69903553T2 (de) 2003-06-26
AR019466A1 (es) 2002-02-20
AU4964699A (en) 2000-02-14
EP1098660B1 (de) 2002-10-16

Similar Documents

Publication Publication Date Title
NO982097D0 (no) Peptider
NO982098D0 (no) Peptider
ATE259241T1 (de) Wässrige peptidzubereitung
ATE317854T1 (de) Hepatitis c inhibitor peptide
DE69722620D1 (de) Nicht-waessrige protische peptidzubereitungen
ATE396204T1 (de) Peptide als antiangiogene arzneimittel
NO985680L (no) Peptidderivater
EP1173467A4 (de) Von chemokinen abgeleitete synthetische peptide
DE60122873D1 (de) Therapeutische porenbildende peptide
NO983849L (no) Peptidderivater
EP1106626A4 (de) Verfahren zur herstellung normaler glykopeptide
ATE226083T1 (de) Verkapselung wasserlöslicher peptide
EP1197556A4 (de) NüTZLICHE POLYPEPTIDE
FR2791348B1 (fr) POLYPEPTIDE Npt2B
EP1159288A4 (de) Alpha-conotoxin-peptide
ATE235511T1 (de) Vielfältig verzweigte peptidkonstruktionen
NO20005547D0 (no) Myelinbasiske proteinpeptider og anvendelser derav
NO20012283D0 (no) Koblede peptider
DE69905636D1 (de) D-Aminoacylase aus Sebekia benihana
NO20013933D0 (no) Peptider
DE69638206D1 (de) Antineoplastische Peptide
EP1032586A4 (de) Hypusin enthaltende peptide
EP1230928A4 (de) Verwendung von peptid
EP1151100A4 (de) Tau-conotoxin peptide
NO20006091D0 (no) Humant protein C-polypeptid

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1098660

Country of ref document: EP

REN Ceased due to non-payment of the annual fee